These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23845456)

  • 1. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
    J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
    Zhou Y; Xu X; Lv H; Wen Q; Li J; Tan L; Li J; Sheng X
    PLoS One; 2016; 11(5):e0155250. PubMed ID: 27227769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
    Huang S; Liao Q; Li W; Deng G; Jia M; Fang Q; Ji H; Meng M
    Bull Cancer; 2021 Apr; 108(4):359-368. PubMed ID: 33743960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP54 is a potential therapeutic target in castration-resistant prostate cancer.
    Zhou C; Zhang X; Ma H; Zhou Y; Meng Y; Chen C; Shi G; Yu W; Zhang J
    BMC Urol; 2024 Feb; 24(1):32. PubMed ID: 38321455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
    Zou P; Chen Z; He Q; Zhuo Y
    Prostate; 2024 Jan; 84(1):64-73. PubMed ID: 37750290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of molecular subtypes identification based on anoikis-related lncRNAs in castration-resistant prostate cancer.
    Chen K; Zhang Y; Li C; Liu Y; Cao Q; Zhang X
    Cell Signal; 2024 May; 117():111104. PubMed ID: 38373667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration-resistant prostate cancer.
    Zhang H; Zhou Y; Feng Y; Hou W; Chen Y; Xing Z; Zhang Y; Wei Q; Yin Y; Guo J; Hu H
    Clin Transl Med; 2024 May; 14(5):e1678. PubMed ID: 38736108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.
    Yadav A; Biswas T; Praveen A; Ganguly P; Bhattacharyya A; Verma A; Datta D; Ateeq B
    Cancer Res Commun; 2023 Oct; 3(10):2044-2061. PubMed ID: 37812088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-like protein 2 induces androgen-independent and malignant behavior in human prostate cancer cells.
    Sato R; Yamasaki M; Hirai K; Matsubara T; Nomura T; Sato F; Mimata H
    Oncol Rep; 2015 Jan; 33(1):58-66. PubMed ID: 25370833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1.
    You H; Song G; Xu Z; Chen S; Shen W; Liu H; Deng B; Li J; Huang G
    J Transl Med; 2024 Feb; 22(1):178. PubMed ID: 38369471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK promotes the progression of castration-resistant prostate cancer.
    Feng Y; Cao H; Wang D; Chen L; Gao R; Sun P
    Acta Biochim Pol; 2023 Dec; 70(4):817-822. PubMed ID: 38099475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KDM5 inhibitor PBIT reduces proliferation of castration-resistant prostate cancer cells via cell cycle arrest and the induction of senescence.
    Smith T; White T; Chen Z; Stewart LV
    Exp Cell Res; 2024 Apr; 437(1):113991. PubMed ID: 38462208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance.
    Xu D; Wang W; Wang D; Ding J; Zhou Y; Zhang W
    Noncoding RNA Res; 2024 Jun; 9(2):388-406. PubMed ID: 38511067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.
    Han Q; Xie QR; Li F; Cheng Y; Wu T; Zhang Y; Lu X; Wong AST; Sha J; Xia W
    Theranostics; 2021; 11(13):6526-6541. PubMed ID: 33995674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA MALAT-1 contributes to maintenance of stem cell-like phenotypes in breast cancer cells.
    Zeng L; Cen Y; Chen J
    Oncol Lett; 2018 Feb; 15(2):2117-2122. PubMed ID: 29434914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer.
    Xin R; Hu B; Qu D; Chen D
    Pulm Pharmacol Ther; 2023 Jan; ():102199. PubMed ID: 36690318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bulk RNA-Seq Combined with Single-Cell Transcriptome Sequencing Reveals the Possible Mechanisms by Which HDGFL3 Involves in Prostate Cancer Growth and Metastasis.
    Xiao C; Liang W
    Arch Esp Urol; 2023 Aug; 76(6):425-438. PubMed ID: 37681334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX.
    Zhong J; Liu D; Yang Q; Ding J; Chen X
    Drug Des Devel Ther; 2024; 18():859-870. PubMed ID: 38524880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.
    Hussein MA; Valinezhad K; Adel E; Munirathinam G
    Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-1 (DKK1) drives growth and metastases in castration-resistant prostate cancer.
    Rinella L; Fiorentino G; Compagno M; Grange C; Cedrino M; Marano F; Bosco O; Vissio E; Delsedime L; D'Amelio P; Bussolati B; Arvat E; Catalano MG
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38740881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.